Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients
Cheng He, Guopei Luo, Lu Yu, et al.
Pancreatology (2016) Vol. 16, Iss. 6, pp. 1080-1084
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
Danielle Benedict Sacdalan, Josephine Anne Lucero, Dennis L. Sacdalan
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 955-965
Open Access | Times Cited: 276
Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
Víctor A. Arrieta, Crismita Dmello, Daniel J. McGrail, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 2
Open Access | Times Cited: 130
Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients
Yongping Zhou, Wei Qian, Junsheng Fan, et al.
Clinica Chimica Acta (2018) Vol. 479, pp. 181-189
Closed Access | Times Cited: 131
Tumor-Infiltrating NETs Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma
Wei Jin, Huaxiang Xu, Shirong Zhang, et al.
Annals of Surgical Oncology (2018) Vol. 26, Iss. 2, pp. 635-643
Closed Access | Times Cited: 103
Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs)
Ye Li, Zhibo Zhang, Yi Hu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 77
Association of blood biomarkers and autoimmunity with immune related adverse events in patients with cancer treated with immune checkpoint inhibitors
Despina Michailidou, Ali Raza Khaki, Maria Pia Morelli, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 59
Prognostic value of platelet-to-lymphocyte ratio in pancreatic cancer: a comprehensive meta-analysis of 17 cohort studies
Yongping Zhou, Sijin Cheng, Abdel Hamid Fathy, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 1899-1908
Open Access | Times Cited: 66
New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer
Guopei Luo, Zhiyao Fan, Cheng He, et al.
Pancreatology (2018) Vol. 18, Iss. 8, pp. 971-976
Closed Access | Times Cited: 64
KrasG12D mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic cancer
Cheng He, Kun Fan, Guopei Luo, et al.
Cancer Letters (2019) Vol. 446, pp. 103-111
Closed Access | Times Cited: 64
A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection
Nicholas Mowbray, David Griffith, Mohammed Hammoda, et al.
HPB (2018) Vol. 20, Iss. 5, pp. 379-384
Open Access | Times Cited: 57
Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer
Yuan Gao, Wenjie Wang, Qiaoming Zhi, et al.
Oncotarget (2017) Vol. 8, Iss. 51, pp. 88835-88844
Open Access | Times Cited: 52
MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer
Kun Fan, Chao Yang, Zhiyao Fan, et al.
Cancer Letters (2018) Vol. 418, pp. 167-175
Closed Access | Times Cited: 52
Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection
Ning Pu, Shanshan Gao, Yadong Xu, et al.
Journal of Cancer (2017) Vol. 8, Iss. 16, pp. 3362-3370
Open Access | Times Cited: 50
Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody
Mehmet Akce, Yuan Liu, Katerina Zakka, et al.
American Journal of Clinical Oncology (2020) Vol. 44, Iss. 2, pp. 74-81
Closed Access | Times Cited: 47
High Systemic Inflammation Response Index (SIRI) Indicates Poor Outcome in Gallbladder Cancer Patients with Surgical Resection: A Single Institution Experience in China
Lejia Sun, Wenmo Hu, Meixi Liu, et al.
Cancer Research and Treatment (2020)
Open Access | Times Cited: 40
Serum Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Prognosticating Immunotherapy Efficacy
Adi Kartolo, Ryan Holstead, Sidra Khalid, et al.
Immunotherapy (2020) Vol. 12, Iss. 11, pp. 785-798
Closed Access | Times Cited: 35
Novel predictors of immune checkpoint inhibitor response and prognosis in advanced non‐small‐cell lung cancer with bone metastasis
Yohei Asano, Norio Yamamoto, Satoru Demura, et al.
Cancer Medicine (2023) Vol. 12, Iss. 11, pp. 12425-12437
Open Access | Times Cited: 13
Significant association between high neutrophil-lymphocyte ratio and poor prognosis in patients with hepatocellular carcinoma: a systematic review and meta-analysis
Chunhua Xu, Fenfang Wu, Lai‐Ling Du, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio
Dongwook Oh, Jung‐Soo Pyo, Byoung Kwan Son
Gastroenterology Research and Practice (2018) Vol. 2018, pp. 1-9
Open Access | Times Cited: 33
The Match between Molecular Subtypes, Histology and Microenvironment of Pancreatic Cancer and Its Relevance for Chemoresistance
Javier Martínez‐Useros, Mario Martin-Galan, Jesús García‐Foncillas
Cancers (2021) Vol. 13, Iss. 2, pp. 322-322
Open Access | Times Cited: 26
Baseline neutrophil-to-lymphocyte ratio (NLR) at the time of diagnosis of liver metastasis is an independent prognostic factor for patients with pancreatic cancer liver metastasis (PCLM)
H. Huang, Wencheng Yin, Hua Zhang, et al.
Research Square (Research Square) (2025)
Open Access
Inflammatory Markers in Predicting Survival in Pancreatic Cancer: A Systematic Review and Meta-analysis
Rinrada Worapongpaiboon, Noppachai Siranart, Patavee Pajareya, et al.
Pancreatology (2025)
Closed Access
<p>The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma</p>
Shuo Li, Huaxiang Xu, Wenquan Wang, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 3327-3337
Open Access | Times Cited: 28
Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12
Yun‐Gyoo Lee, Hyun Chang, Bhumsuk Keam, et al.
Cancer Research and Treatment (2020) Vol. 53, Iss. 3, pp. 671-677
Open Access | Times Cited: 24
Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancer
Akhil Chawla, Tiffany L. Huang, Andrew Ibrahim, et al.
HPB (2017) Vol. 20, Iss. 5, pp. 398-404
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top